Effects of Antidiabetic Drugs on Gut Microbiota Composition
Open accessThe DOI matches its Crossref record; 82 of the 85 references it cites were found in a registry or an index.
Abstract
Gut microbiota forms a catalog of about 1000 bacterial species; which mainly belong to the Firmicutes and Bacteroidetes phyla. Microbial genes are essential for key metabolic processes; such as the biosynthesis of short-chain fatty acids (SCFA); amino acids; bile acids or vitamins. It is becoming clear that gut microbiota is playing a prevalent role in pathologies such as metabolic syndrome; type 2 diabetes (T2D); inflammatory and bowel diseases. Obesity and related diseases; notably type 2 diabetes, induce gut dysbiosis. In this review; we aim to cover the current knowledge about the effects of antidiabetic drugs on gut microbiota diversity and composition as well as the potential beneficial effects mediated by specific taxa. Metformin is the first-line treatment against T2D. In addition to its glucose-lowering and insulin sensitizing effects, metformin promotes SCFA-producing and mucin-degrading bacteria. Other antidiabetic drugs discussed in this review show positive effects on dysbiosis; but without any consensus specifically regarding the Firmicutes to Bacteroidetes ratio. Thus, beneficial effects might be mediated by specific taxa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, the most studied medication is metformin, which seems to positively influence microbiota diversity and composition [61].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [61]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 5×
“High-fat diet promotes taxa belonging to the Firmicutes (Clostridium ramosum) and Proteobacteria (Bilophila wadsworthia), while high-fiber diet increases the abundance in Bacteroidetes (Prevotella, Xylanibactera), Verrucomicrobia (Akkermansia muciniphila) and Actinobacteria (Bifidobacterium spp.) and decreases the amo…”
BackgroundInfluentialDiet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Gut microbiota composition and diversity is predominantly influenced by the diet [6,34,42].”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913 · cited 2×
“They are modulated by the diet, host health, age, ethnicity and genetics and thus are unique and highly variable among individuals [2,3].”
BackgroundA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 1×
“Nevertheless, Turnbaugh and colleagues [4] suggest that there is a “core gut microbiome” (i.”
BackgroundHuman gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815 · cited 2×
“They are modulated by the diet, host health, age, ethnicity and genetics and thus are unique and highly variable among individuals [2,3].”
BackgroundEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 6×
“Whereas Escherichia probably plays an important role in the side-effects of metformin [19], Bifidobacterium adolescentis has been shown to negatively correlate to HbA1c.”
BackgroundInfluentialEckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Cited by
Items 101–135 of 135
Farup, P. G., & Valeur, J. (2018) · Behavioral Sciences · doi:10.3390/bs8100089 · Cited by 8
Wei, C., Xu, X., Zhang, J., Wang, X., Han, T., Zhang, Y., Pan, S., Zhu, M., Li, R., Lou, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58937-6 · Cited by 7
“A notable strength lies in our focus on prediabetic individuals who are not taking hypoglycemic agents, as many studies have demonstrated that hypoglycemic agents can signi fi cantly modulate the gut microbiome 48 .”
Shevchenko, T. M., Rozhnyeva, I. L., Дикленко, Т. В., & Voronkova, O. S. (2017) · Regulatory Mechanisms in Biosystems · doi:10.15421/021776 · Cited by 7
“Причини порушення рівноваги різні: зміни екологічного стану довкілля, нераціональне харчування, вживання шкідливих продуктів, гострі кишкові інфекції, хронічні захворювання та дисфункція шлунково-кишкового тракту, широке застосування антибіотиків, зниження імунологічної реактивності організму тощо (Brown et al., 2012;…”
Metabolic consequences of alterations in gut microbiota induced by antidiabetic medications
Chaithanya, V., Kumar, J. S., Leela, K. V., Angelin, M., Satheesan, A., & Murugesan, R. (2023) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2023.100180 · Cited by 6
Gut Microbiota and Nutrition: Strategies for the Prevention and Treatment of Type 2 Diabetes
Sastre, M., Cimbalo, A., Mañes, J., & Manyes, L. (2024) · Journal of Medicinal Food · doi:10.1089/jmf.2022.0154 · Cited by 7
Oral insulin does not alter gut microbiota composition of NOD mice
Kihl, P., Krych, Ł., Buschard, K., Wesley, J. D., Kot, W., Hansen, A. K., Nielsen, D. S., & von Herrath, M. G. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3010 · Cited by 6
Association between equol producers and type 2 diabetes mellitus among Japanese older adults
Hamaura, K., Murakami, H., Tamura, A., Matsuki, K., Sato, E., Tanabe, J., Yanagimachi, M., Oishi, M., Iino, K., Okuyama, S., et al. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13995 · Cited by 6
Impact of SGLT Inhibitors on Multiple Organ Defects in Diabetes
Asrih, M., & Gariani, K. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666191105151828 · Cited by 4
Ruíz-Tóvar, J., Llavero, C., & Fernández-Contreras, M. E. (2023) · Nutrients · doi:10.3390/nu15214549 · Cited by 4
“The improvement in this ratio has often been related to weight loss and intestinal inflammation and permeabilization [25].”
BackgroundLisco, G., Tullio, A. D., Zupo, R., Prete, M., Piazzolla, G., Racanelli, V., & Triggiani, V. (2025) · Immunologic Research · doi:10.1007/s12026-025-09655-0 · Cited by 4
“All the authors approved the final version of the paper and approved the manuscript submission.”
Sojan, A., & Xu, B. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106972 · Cited by 3
Mrozińska, S., Gosiewski, T., Sroka-Oleksiak, A., Szopa, M., Bulanda, M., Malecki, M. T., & Klupa, T. (2020) · Clinical Diabetology · doi:10.5603/dk.2019.0024 · Cited by 3
“Some other antidiabetic medications, including liraglutide and acarbose, are also postulated to modify gut microbiota [12].”
BackgroundRole of Gut Microbiota in Pathogenesis and Treatment of Type 2 Diabetes
Duggal, N., & Kapoor, S. (2021) · Eurasian Journal of Medicine and Oncology · doi:10.14744/ejmo.2021.56223 · Cited by 3
“[60] Metformin promotes the development of SCFA-producing bacteria that include Blautia, Bacteroides, Butyricoccus, and Phascolarctobacterium, as well as the Proteobacteria phylum; the genera Allobaculum and Lactobacillus.”
BackgroundDrug-Based Strategies for Weight Reduction and Their Interaction with the Human Gut Microbiota
Lee, V., Kim, E., & Singh, J. (2025) · Annals of Pharmacy Practice and Pharmacotherapy · doi:10.51847/oobvhfczjv · Cited by 2
Al-Rawe, A. M., & Suleiman, A. A. (2020) · Iraqi Journal of Science · doi:10.24996/ijs.2020.61.2.4 · Cited by 2
Shyshkan-Shyshova, К. О., Zinych, О. В., Кushnareva, N. M., Ковальчук, А., & Prybyla, О. В. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.8.2021.246792 · Cited by 3
Pharmacological methods for weight reduction and their connection with the human gut microbiota
Denchev, V. D., & Handjieva‐Darlenska, T. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e114567 · Cited by 1
“…composition and function of GI tract bacteria – there is emerging evidence that the presence of such a connection is not only plausible but also very probable and it may give researchers insight into the pathogenesis of such metabolic diseases (Montandon and Jornayvaz 2017; Xourgia et al. 2019).”
BackgroundResultInfluentialA pro-, pre- és szinbiotikumok hatása a szénhidrát-, illetve lipidanyagcserére
Tomasics, G., Schandl, L., Polyák, A., & Winkler, G. (2024) · Orvosi Hetilap · doi:10.1556/650.2024.33064 · Cited by 1
Sa’ad-Aldin, K., & Altamimi, M. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0689-z · Cited by 2
“On the other hand, it was reported that Bifidobacterium adolescentis negatively associate with HbA1c [40], which may explain glucose lowering effects of diet increasing its level, such as plant-based diet.”
BackgroundLiu, Y.-K., Xu, X., & Zhou, X. (2019) · PubMed Central · doi:10.7518/hxkq.2019.05.020 · Cited by 2
The role of the gut microbiota in the regulation of incretin effects
Shyshkan-Shyshova, К. О., & Zinych, O. V. (2020) · Clinical endocrinology and endocrine surgery · doi:10.30978/cees-2020-1-64 · Cited by 1
Medication and Health Risks Associated With Neglected Side Effects on Gut Microbiota
Velikova, T. V., Nakov, R., & Ianiro, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00074-7 · Cited by 1
ДНІСТРЯНСЬКА, А. П., Musienko, O. S., & Yaremchuk, L. V. (2019) · Reports of Vinnytsia National Medical University · doi:10.31393/reports-vnmedical-2019-23(4)-16 · Cited by 1
Wang, X., Wang, Z., Liu, D., Jiang, H., Cai, C., Li, G., & Yu, G. (2021) · Research Square · doi:10.21203/rs.3.rs-754308/v1
Almousawy, M. H., & Jabir, F. A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22164953
Study on Diabetic Rats Comparing the Effects of Sitagliptin and Probiotics on Serum Glucose
Lateef, N., Rehman, I., Tahir, M., Tahir, M. N., ., A., & Memon, F. A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs221651135
Maldini, A. C., Calvo, M. L., Schlinder, A., HEREDIA, V. V. O., Marco, R. D., Forlin, G. M. E., González, J. P., Apoloni, S. B., Burgos, M. A., López, C. E., et al. (2023) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v57i1.680
Nonalcoholic Fatty Liver Disease, Procalcitonin, and Gut Microbiota: Players in the Same Team
Georgescu, D., Lascu, A., Ioniță, I., Ancusa, O., Ionita, M., Rosca, C. I., Călămar-Popovici, D., & Lighezan, D. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.110134
Nkeck, J. R., Tchuisseu‐Kwangoua, L. A., Pelda, A., Tamko, W. C., Hamadjoda, S., Essama, D. B., Fojo, B., Niasse, M., Diallo, S., & Ngandeu-Singwé, M. (2024) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.240224.cap
“115,116 Other antidiabetic agents not used for weight loss, such as metformin, sita-gliptin and acarbose, may among other effects reduce the synthesis of short-chain fatty acids in the gut and help restore the balance of the microbiome.”
BackgroundMicrobiota intestinale e farmaci ipoglicemizzanti: la comunicazione che cura
Rubino, M., Cassano, V., & Hribal, M. L. (2025) · il Diabete · doi:10.30682/ildia2501c
Recent advances in natural antidiabetics
Anand, A., Manjula, S. N., & Kenganora, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30086-8.00004-8
Novel Therapies: Pharmacological Approaches to Modulate the Gut Microbiome in Metabolic Syndrome
Gunjan, & Vidić, J. (2025) · Springer eBooks · doi:10.1007/978-981-96-6246-3_5
Savytska, M., Kyriienko, D., Mykhalchyshyn, G., Tsyryuk, O., Falalyeyeva, T. M., & Kobyliak, N. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-07861-2
“…into account the fact that antidiabetic drugs such as metformin, peroxisome proliferator-activated receptor γ (PPAR-γ) agonists, α-glucosidase inhibitors, GLP-1 agonists, DPP-4 inhibitors and sodium/glucose cotransporter (SGLT) inhibitors could change the composition of the gut microbiota 40,41 .”
Una revisión histórica de las glucocininas y los péptidos similares a la insulina
Hernández-López, A., Dinkova, T. D., & Alejandre, A. X. Á. (2025) · TIP Revista Especializada en Ciencias Químico-Biológicas · doi:10.22201/fesz.23958723e.2025.759
“En un estudio muy interesante, realizado por Montandon & Jornayvaz (2017) se observó que la microbiota intestinal se modifica durante el tratamiento con agentes antidiabéticos y que la metformina interviene en la disminución de la glucosa e incrementa la sensibilidad a la insulina, al promover la…”
Écale, F. (2021) · theses.fr (ABES) · doi:10.70675/f456a090zae0fz489czb8e9z6739bf2d74ae · Cited by 1
Metadata
- Authors
- Montandon, S., & Jornayvaz, F.
- Affiliations
- University Hospital of Geneva (CH)
- Corresponding author
- Jornayvaz, François
- ORCID
- Jornayvaz, François
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2017-09-30
- Volume
- 8
- Issue
- 10
- Pages
- 250
- ISSN
- 2073-4425 (ISSN-L)
- PMC
- PMC5664100
- OpenAlex
- W2756853277
- Cited by
- 135
- References
- 85
- Citations by year
- 2025: 17 · 2024: 14 · 2023: 20 · 2022: 16 · 2021: 17 · 2020: 20 · 2019: 16 · 2018: 14 · 2017: 1
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Genes (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Novo Nordisk
- Gottfried und Julia Bangerter-Rhyner-Stiftung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, antidiabetic drugs, type 2 diabetes, metformin, short-chain fatty acids, gut dysbiosis, Firmicutes/Bacteroidetes ratio, mucin-degrading bacteria, obesity, microbial taxa, bile acids, insulin sensitivity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.